期刊文献+

Decoy核酸在前列腺癌LNCaP细胞株中的作用及其机制

The role of decoy nuclear acid in LNCaP cells
原文传递
导出
摘要 目的 观察雄激素受体反应元件陷阱核酸(ARE decoy DNA)在LNCaP细胞中的致凋亡作用及下游信号通路.方法 根据ARE-Ⅰ、ARE-Ⅱ人工合成decoy核酸,进行部分和完全硫代修饰,应用凝胶阻抑分析方法检测4种decoy核酸与雄激素受体(AR)特异性结合.选择特异性结合最强decoy核酸通过LipofectinTM 2000转染细胞,MTS法检测转染后细胞增殖能力,共聚焦显微镜观察细胞形态学改变,Western blot检测细胞内蛋白表达.结果 ARE-Ⅱdecoy转染后MTS检测细胞A值0.500±0.013(48 h),与对照decoy转染组0.750±0.055(48 h)比较差异有统计学意义(P<0.01).细胞核皱缩,核染色质分块,DNA电泳出现阶梯状ladder,证明细胞发生凋亡.Western blot检测发现细胞内p-Akt表达明显降低(P<0.05),Akt信号通路被抑制,促进了细胞凋亡.结论 ARE-Ⅱdecoy核酸明显抑制前列腺癌LNCaP细胞生长,促进细胞凋亡,改变细胞内信号通路. Objective To investigate the role of "androgen responsive element (ARE) decoy" in LNCaP cells and its downstream signal pathway. Methods Four kinds of decoy with DNA-protein interactions were detected by gel shift assay ( EMSA). Then LNCaP cells were transfected with the ARE decoy by LipofectinTM 2000.Cell viability was detected by MTS assay, and apoptosis was examined by DNA fragmentation. Confocal microscopy was used to observe cell morphology changes, and Western blotting analysis was used to detect p-Akt protein changes. Results MTS assay showed cellular proliferation was inhibited significantly by ARE- Ⅲdecoy with total sulfurized A value being 0.500 ±0.013 (48 h) as compared with control decoy [0.750 ±0.055 (48 h) , (P 〈0.01) ]. Morphologcally, apoptosis occurred in transfected cells. Western blotting analysis revealed a significant reduction of p-Akt protein ( P 〈 0.05). Conclusion Total sulfurized ARE- D decoy had an antiandrogen effect and induced apoptosis in LNCaP cells by reducing the p-Akt protein expression.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2010年第8期1139-1141,共3页 Chinese Journal of Experimental Surgery
基金 国家自然科学基金资助项目(30772162)
关键词 前列腺癌 雄激素受体 LNCAP Decoy核酸 Carcinoma of prostate Androgen receptor LNCaP Decoy double-stranded oli-gonucleotide
  • 相关文献

参考文献13

  • 1Kung HJ,Evans CP.Oncogenic activation of androgen receptor.Urol Oncol,2009,27:48 -52.
  • 2Montgomery BT,Yourg CY,Bihartz DL,et al.Hormonal regulation of prostate-specific antigen (PSA) glycoprotein in the human prostatic adenocarcinoma cell line,LNCaP.Prostate,1992,21:63-73.
  • 3Young CYF,Montgomery BT.Hormonal regulation of prostate-specific antigen mRNA in a human prostatic adenocarcinoma cell line LNCaP.Cancer Res,1991,51:3478-3752.
  • 4赵军,童强松,郑丽端,曾甫清,鲁功成.反义寡核苷酸阻断雄激素受体表达对前列腺癌细胞生长活性的影响[J].中华泌尿外科杂志,2003,24(4):266-268. 被引量:4
  • 5王洛夫,江军,方玉华,靳风烁,靳文生.雄激素受体反义寡核苷酸对前列腺癌细胞生长的抑制作用[J].中华泌尿外科杂志,2003,24(6):383-385. 被引量:6
  • 6Linja MJ,Savinainen KJ,Saramaki OR,et al.Amplification and overexpression of androgen receptor gene in hormone refractory prostate cancer.Cancer Res,2001,61:3550-3555.
  • 7Veldscholte J,Berrevoets CA,Ris-Stalpers C,et al.The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens.J Steroid Biochem Mol Biol,1992,41:665-669.
  • 8Gregory CW,He B,Johnson RT,et al.A mechanism for androgen receptor mediated prostate cancer recurrence after androgen deprivation therapy.Cancer Res,2001,61:4315-4319.
  • 9Taplin ME,Balk SP.Androgen receptor:A key molecule in the progression of prostate cancer to hormone independence.J Cell Biochem,2004,91:483-490.
  • 10Wang G,Sadar MD.Amino-terminus domain of the androgen receptor as a molecular target to prevent the hormonalprogression of prostate cancer.J Cell Biochem,2006,98:36-53.

二级参考文献26

  • 1杨军,胡新华,张强.缺氧诱导因子-1α在腹主动脉瘤中的表达及其意义[J].中华实验外科杂志,2004,21(6):702-704. 被引量:4
  • 2高晓康,王禾,刘哲.强力霉素抑制前列腺癌细胞PC-3增殖的体外研究[J].现代泌尿外科杂志,2001,6(3):27-29. 被引量:2
  • 3J.萨姆布鲁克等著.金冬雁 等译.分子克隆实验指南:第2版[M].北京:科学技术出版社,1992.888-897.
  • 4Koivisto P, Kolmer M, Visakorpi T, et al. Androgen receptor gene and hormonal therapy failure of prostate cancer. Am J Pathol, 1998,152 : 1 -9.
  • 5Jenster G. The role of androgen receptor in the development and progression of prostate cancer. Semin Oncol, 1999,26:407-421.
  • 6Agrawal S. Antisense oligonucleotides: towards clinical trial. Trends Biotechnol, 1996,14:376-387.
  • 7Agrawal S,Zhao Q. Antisense therapeutics. Current Opin Chem Biol,1998,2:519-528.
  • 8Wagner RW, Flanagan WM. Antisense technology and prospects for therapy of viral infections and cancer. Mol Med Today, 1997,3 : 31 -38.
  • 9Galderisi U, Cascino A, Giordano A. Antisense oligonucleotides as therapeutic agents. J Cell Physil, 1999,181:251-257.
  • 10Chen S, Song CS, Lavrovsky Y, et al. Catalytic cleavage of the androgen receptor messenger RNA and functional inhibition of androgen receptor activity by a hammerhead ribozyme. Mol Endocrinol, 1998,12 :1558-1566.

共引文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部